Why Is The Milestone Pharmaceuticals (MIST) Stock Rocketing In The Pre-Hours Session?
Following positive clinical-trial findings, shares of Milestone Pharmaceuticals Inc. (NASD: MIST) were up 33.92% to trade at $11.37 in pre-market at the last check. MIST stock ended Friday’s session down -5.14% with 0.13 million shares changing hands. What was shared by MIST? In patients with paroxysmal supraventricular tachycardia, Milestone Pharmaceuticals (MIST) today reported encouraging topline […]